EDN1 and glaucoma: Increased presence of ET-1 in the AH is believed to contribute to the pathogenesis of the outflow pathway in eyes with POAG [28], [60], [61], [63] and inhibition of ET-1 signaling is considered to be one of the new potential approaches to the treatment of glaucoma [62], [71].